PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00319865 · UNKNOWN

Trial details

NCT number: NCT00319865
Sponsor: Korean Multiple Myeloma Working Party
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2005-11-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.